Sight Sciences (SGHT) Competitors $3.51 +0.17 (+5.09%) Closing price 04:00 PM EasternExtended Trading$3.52 +0.01 (+0.14%) As of 04:02 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SGHT vs. KMTS, SIBN, IRMD, CBLL, EMBC, BBNX, AVNS, BVS, KIDS, and RXSTShould you be buying Sight Sciences stock or one of its competitors? The main competitors of Sight Sciences include Kestra Medical Technologies (KMTS), SiBone (SIBN), iRadimed (IRMD), CeriBell (CBLL), Embecta (EMBC), Beta Bionics (BBNX), AVANOS MEDICAL (AVNS), Bioventus (BVS), OrthoPediatrics (KIDS), and RxSight (RXST). These companies are all part of the "medical equipment" industry. Sight Sciences vs. Its Competitors Kestra Medical Technologies SiBone iRadimed CeriBell Embecta Beta Bionics AVANOS MEDICAL Bioventus OrthoPediatrics RxSight Kestra Medical Technologies (NASDAQ:KMTS) and Sight Sciences (NASDAQ:SGHT) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, risk, earnings, dividends and institutional ownership. Do analysts recommend KMTS or SGHT? Kestra Medical Technologies currently has a consensus price target of $27.50, suggesting a potential upside of 79.15%. Sight Sciences has a consensus price target of $3.93, suggesting a potential upside of 12.06%. Given Kestra Medical Technologies' stronger consensus rating and higher possible upside, equities research analysts clearly believe Kestra Medical Technologies is more favorable than Sight Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Kestra Medical Technologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Sight Sciences 0 Sell rating(s) 5 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.29 Is KMTS or SGHT more profitable? Kestra Medical Technologies has a net margin of 0.00% compared to Sight Sciences' net margin of -63.24%. Kestra Medical Technologies' return on equity of 0.00% beat Sight Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Kestra Medical TechnologiesN/A N/A N/A Sight Sciences -63.24%-54.62%-34.92% Which has higher earnings and valuation, KMTS or SGHT? Kestra Medical Technologies has higher earnings, but lower revenue than Sight Sciences. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioKestra Medical Technologies$59.81M13.18N/AN/AN/ASight Sciences$79.87M2.27-$51.51M-$0.98-3.58 Do insiders and institutionals hold more shares of KMTS or SGHT? 55.5% of Sight Sciences shares are owned by institutional investors. 30.9% of Sight Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Does the media favor KMTS or SGHT? In the previous week, Kestra Medical Technologies had 6 more articles in the media than Sight Sciences. MarketBeat recorded 10 mentions for Kestra Medical Technologies and 4 mentions for Sight Sciences. Sight Sciences' average media sentiment score of 0.84 beat Kestra Medical Technologies' score of 0.26 indicating that Sight Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Kestra Medical Technologies 3 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral Sight Sciences 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryKestra Medical Technologies beats Sight Sciences on 8 of the 12 factors compared between the two stocks. Get Sight Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for SGHT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SGHT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SGHT vs. The Competition Export to ExcelMetricSight SciencesMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$172.66M$6.67B$5.57B$9.31BDividend YieldN/A1.20%4.23%4.03%P/E RatioN/A25.4928.6119.73Price / Sales2.2787.66412.31173.11Price / CashN/A20.3636.0257.96Price / Book2.044.668.235.67Net Income-$51.51M$174.76M$3.23B$257.79M7 Day Performance-0.28%-1.13%-0.01%0.52%1 Month Performance-16.63%1.21%5.61%8.84%1 Year Performance-57.76%2.34%26.52%14.18% Sight Sciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SGHTSight Sciences1.6073 of 5 stars$3.51+5.1%$3.93+12.1%-57.3%$172.66M$79.87M0.00210News CoverageAnalyst ForecastKMTSKestra Medical TechnologiesN/A$14.75-5.9%$27.50+86.4%N/A$804.64M$52.64M0.00300News CoverageSIBNSiBone3.976 of 5 stars$18.01-2.5%$22.50+24.9%+8.6%$787.09M$167.18M-28.14350Positive NewsIRMDiRadimed4.7096 of 5 stars$59.02-4.5%$72.00+22.0%+25.8%$785.79M$73.24M38.08110Positive NewsCBLLCeriBell2.6022 of 5 stars$17.20-9.1%$32.14+86.9%N/A$684.19M$65.44M0.00N/AEMBCEmbecta4.7553 of 5 stars$10.03-2.8%$19.33+92.8%-25.4%$603.13M$1.08B11.142,100News CoveragePositive NewsAnalyst ForecastBBNXBeta BionicsN/A$13.40-0.9%$23.44+75.0%N/A$586.18M$65.12M0.00294AVNSAVANOS MEDICAL2.8694 of 5 stars$11.87-3.9%N/A-44.8%$571.11M$687.80M-1.422,227News CoverageBVSBioventus2.7114 of 5 stars$6.82-2.8%$13.75+101.6%-4.3%$560.22M$567.70M-11.181,200KIDSOrthoPediatrics4.2664 of 5 stars$21.24-5.5%$35.83+68.7%-33.1%$545.96M$204.73M-12.14200News CoveragePositive NewsAnalyst ForecastRXSTRxSight2.2272 of 5 stars$12.43-4.8%$37.90+204.9%-84.7%$530.31M$139.93M-18.55220Analyst Downgrade Related Companies and Tools Related Companies KMTS Alternatives SIBN Alternatives IRMD Alternatives CBLL Alternatives EMBC Alternatives BBNX Alternatives AVNS Alternatives BVS Alternatives KIDS Alternatives RXST Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SGHT) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett’s Little-Known Succession PlanYou could miss out on millions buying a house - even if prices rise Joel Litman is a millionaire member of ...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sight Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sight Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SGHT Stock Alerts